Original citation: J Clin Invest. 2011;121(8):3176–3188. https://doi.org/10.1172/JCI41695
Citation for this corrigendum: J Clin Invest. 2026;136(5):e204857. https://doi.org/10.1172/JCI204857
In Figure 1A of the original article, the H&E-stained images for the Wcre;Trp53fl/fl and Human ILC samples as well as the E-cadherin-stained images for the K14cre;Cdh1fl/fl;Trp53fl/fl and Human ILC samples were incorrect and were inadvertently duplicated from a prior publication in Cancer Cell (1). In addition, the H&E-stained image for the K14cre;Cdh1fl/fl;Trp53fl/fl sample and all of the p120-stained images have been replaced. The corrected figure panel, based on the original source material and data, is provided below.
The authors regret the errors.
Version 1. 03/02/2026
Electronic publication
Footnotes
Contributor Information
Miranda van Amersfoort, Email: M.vanamersfoort-2@umcutrecht.nl.
Jos Jonkers, Email: j.jonkers@nki.nl.
References
- 1.Derksen PWB, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006;10(5):437–449. doi: 10.1016/j.ccr.2006.09.013. [DOI] [PubMed] [Google Scholar]